Adenoid cystic carcinoma (ACC) is a rare malignancy of the secretory glands with a high tendency to invade adjacent tissue and spread to the lung, bone or liver. No treatments other than surgery or ...

Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...

A novel once-daily drug showed a comparable efficacy and safety profile as the standard-of-care drug in patients with cystic ...

£500K grant for the development of precision antibiotics targeting AMR lung infections in people with cystic fibrosis.

I spent my childhood and young adulthood being told I was “too young and healthy” to be dealing with the health issues I experienced. But as an adult, I was determined to find answers, and eventually, ...

This typically requires antibiotic treatment; however, the bacteria may become resistant to antibiotics over time, leading to antimicrobial resistance (AMR). Glox Therapeutics’ proprietary protein ...

Glox Therapeutics Ltd. has been awarded a share of a £3 million (US$3.7 million) collaborative discovery program launched by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) syndicate. The ...

Patients were followed-up for around six years after transplantation. The main underlying diseases affecting patients were chronic obstructive pulmonary disease, cystic fibrosis and interstitial lung ...